110 related articles for article (PubMed ID: 21302360)
1. Comparison of a pair of synthetic tea-catechin-derived epimers: synthesis, antifolate activity, and tyrosinase-mediated activation in melanoma.
Sáez-Ayala M; Sánchez-del-Campo L; Montenegro MF; Chazarra S; Tárraga A; Cabezas-Herrera J; Rodríguez-López JN
ChemMedChem; 2011 Mar; 6(3):440-9. PubMed ID: 21302360
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
Sánchez-del-Campo L; Otón F; Tárraga A; Cabezas-Herrera J; Chazarra S; Rodríguez-López JN
J Med Chem; 2008 Apr; 51(7):2018-26. PubMed ID: 18324763
[TBL] [Abstract][Full Text] [Related]
3. Melanoma activation of 3-o-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin to a potent irreversible inhibitor of dihydrofolate reductase.
Sánchez-del-Campo L; Tárraga A; Montenegro MF; Cabezas-Herrera J; Rodríguez-López JN
Mol Pharm; 2009; 6(3):883-94. PubMed ID: 19358568
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin.
Sánchez-del-Campo L; Chazarra S; Montenegro MF; Cabezas-Herrera J; Rodríguez-López JN
J Cell Biochem; 2010 Aug; 110(6):1399-409. PubMed ID: 20564235
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the antifolate activity of synthetic tea-derived catechins.
Sáez-Ayala M; Fernández-Pérez MP; Chazarra S; Mchedlishvili N; Tárraga-Tomás A; Rodríguez-López JN
Molecules; 2013 Jul; 18(7):8319-41. PubMed ID: 23863773
[TBL] [Abstract][Full Text] [Related]
6. The antifolate activity of tea catechins.
Navarro-Perán E; Cabezas-Herrera J; García-Cánovas F; Durrant MC; Thorneley RN; Rodríguez-López JN
Cancer Res; 2005 Mar; 65(6):2059-64. PubMed ID: 15781612
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
[TBL] [Abstract][Full Text] [Related]
8. Binding of natural and synthetic polyphenols to human dihydrofolate reductase.
Sánchez-Del-Campo L; Sáez-Ayala M; Chazarra S; Cabezas-Herrera J; Rodríguez-López JN
Int J Mol Sci; 2009 Dec; 10(12):5398-5410. PubMed ID: 20054477
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate.
Spina M; Cuccioloni M; Mozzicafreddo M; Montecchia F; Pucciarelli S; Eleuteri AM; Fioretti E; Angeletti M
Proteins; 2008 Jul; 72(1):240-51. PubMed ID: 18214969
[TBL] [Abstract][Full Text] [Related]
10. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
Singh P; Kaur M; Sachdeva S
J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
[TBL] [Abstract][Full Text] [Related]
11. Effects of a synthetic antitumoral catechin and its tyrosinase-processed product on the structural properties of phosphatidylcholine membranes.
How CW; Teruel JA; Ortiz A; Montenegro MF; Rodríguez-López JN; Aranda FJ
Biochim Biophys Acta; 2014 May; 1838(5):1215-24. PubMed ID: 24518157
[TBL] [Abstract][Full Text] [Related]
12. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate.
Navarro-Perán E; Cabezas-Herrera J; Campo LS; Rodríguez-López JN
Int J Biochem Cell Biol; 2007; 39(12):2215-25. PubMed ID: 17683969
[TBL] [Abstract][Full Text] [Related]
13. Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin.
Sánchez-del-Campo L; Rodríguez-López JN
Int J Cancer; 2008 Nov; 123(10):2446-55. PubMed ID: 18729182
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
15. The antifolate activity of tea catechins.
Lucock MD; Roach PD
Cancer Res; 2005 Sep; 65(18):8573. PubMed ID: 16166339
[No Abstract] [Full Text] [Related]
16. Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate: relationship between epimerization and chemical structure.
Suzuki M; Sano M; Yoshida R; Degawa M; Miyase T; Maeda-Yamamoto M
J Agric Food Chem; 2003 Jan; 51(2):510-4. PubMed ID: 12517118
[TBL] [Abstract][Full Text] [Related]
17. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives.
Lambert JD; Rice JE; Hong J; Hou Z; Yang CS
Bioorg Med Chem Lett; 2005 Feb; 15(4):873-6. PubMed ID: 15686878
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of green tea polyphenols and the biological activities of those metabolites.
Lambert JD; Sang S; Yang CS
Mol Pharm; 2007; 4(6):819-25. PubMed ID: 17963356
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
Park KD; Cho SJ
Eur J Med Chem; 2010 Mar; 45(3):1028-33. PubMed ID: 19962795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
